Literature DB >> 7370060

Antigen-induced arthritis. Studies on the inhibition of proteoglycan synthesis observed in articular cartilage during short-term joint inflammation.

J D Sandy, D A Lowther, H L Brown.   

Abstract

During the acute phase of antigen-induced arthritis, cartilage was obtained from five different sites within the joint, and chondrocyte activity was assessed by autoradiography of sections labeled with 35S-sulfate. There was a marked inhibition of chondrocyte proteoglycan synthesis in all weight-bearing areas; in addition, the complete superficial layer of cells and many mid-zone cells in these areas were completely inactive. Electron microscopy showed that the inactive surface cells had degenerated completely, and that many mid-zone cells contained an accumulation of intracytoplasmic filaments and were depleted in biosynthetic organelles. A biochemical study of the inhibition showed that: 1) the incorporation of 35S-sulfate and 3H-acetate into glycosaminoglycans was inhibited to a similar extent; 2) the inhibition of glycosaminoglycan synthesis could not be reversed either by the addition of benzyl-beta-D-xyloside to incubations or by maintenance of the cartilage in organ culture for 6 days; 3) the inhibited chondrocytes exhibited a decreased ability to secrete proteoglycans into the extracellular fraction of the cartilage.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370060     DOI: 10.1002/art.1780230406

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

1.  Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular cartilage.

Authors:  J Schalkwijk; L A Joosten; W B van den Berg; L B van de Putte
Journal:  Agents Actions       Date:  1988-02

Review 2.  Cytokine modulation of chondrocyte metabolism--in vivo and in vitro effects of piroxicam.

Authors:  J H Herman; A M Appel; R C Khosla; K S Kelch; E V Hess
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

3.  Structural and biochemical abnormalities of articular cartilage in rheumatoid arthritis.

Authors:  D R Mitrovic; N Darmon
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death.

Authors:  W B van den Berg; M W Kruijsen; L B van de Putte; H J van Beusekom; M van der Sluis-van der Pol; W A Zwarts
Journal:  Br J Exp Pathol       Date:  1981-06

5.  Conditioned medium from stimulated mononuclear leucocytes potentiates the ability of human neutrophils to damage human articular cartilage.

Authors:  E J Bates; I C Kowanko; A Ferrante
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

6.  Elastase secreted by activated polymorphonuclear leucocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: escape from inactivation by alpha-1-proteinase inhibitor.

Authors:  J Schalkwijk; W B van den Berg; L B van de Putte; L A Joosten
Journal:  Br J Exp Pathol       Date:  1987-02

7.  Oxygen free-radicals mediate an inhibition of proteoglycan synthesis in cultured articular cartilage.

Authors:  E J Bates; D A Lowther; C J Handley
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

8.  Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis.

Authors:  P J Verschure; J van Marle; L A Joosten; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

9.  Evidence for polymorphonuclear-leucocyte-derived proteinases in arthritic cartilage.

Authors:  J D Sandy; A Sriratana; H L Brown; D A Lowther
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

10.  Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac.

Authors:  M A Hayward; G A Howard; R G Neuman; D D Wood; B M Weichman; D C Van Sickle
Journal:  Agents Actions       Date:  1989-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.